12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Deals

Mundipharma, Shionogi deal

Shionogi gained exclusive, Japanese rights to develop and commercialize Mundipharma's OxyContin Neo oxycodone and Targin oxycodone/naloxone to...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >